First Solar, Intermolecular Extend, Expand Licensing Deal
Intermolecular, Inc. (Nasdaq: IMI) and First Solar, Inc. (Nasdaq: FSLR) today announced they have entered into a two-year collaboration and licensing agreement focused on further increases to the conversion efficiency of First Solar's cadmium telluride (CdTe) solar cell technology. Under the new collaborative development program, First Solar and Intermolecular researchers will work together to develop disruptive new approaches to increasing the performance of CdTe solar cell technology using Intermolecular's proprietary High Productivity Combinatorial (HPC™) platform. The program targets substantial gains in First Solar's module conversion efficiency beyond its previously announced roadmap.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.